Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study

Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study

Algeria has adopted a therapeutic protocol using hydroxychloroquine (HCQ) as a first-line treatment for patients with coronavirus disease 2019 (COVID-19). The administration of HCQ must be accompanied by appropriate cardiac and therapeutic pharmacological monitoring to avoid side effects and toxicit...

Full description

Bibliographic Details
Main Authors: Saadi Fatima Zohra, Lachgueur Nassima
Format: Article
Language:English
Published: Taylor & Francis Group 2021-06-01
Series:Forensic Sciences Research
Subjects:
forensic sciences
concentration
covid-2019
hydroxychloroquine
hplc-dad
plasma
Online Access:http://dx.doi.org/10.1080/20961790.2021.1936896

Internet

http://dx.doi.org/10.1080/20961790.2021.1936896

Similar Items